Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

26.03
-0.6900-2.58%
Post-market: 26.030.00000.00%18:31 EDT
Volume:272.07K
Turnover:7.14M
Market Cap:1.90B
PE:-110.46
High:27.14
Open:26.86
Low:26.01
Close:26.72
Loading ...
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Major Issues Report

Current report, item 5.02
Jan 13, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Dec 16, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Nov 14, 2019

Major Issues Report

Current report, item 5.02
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 28, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 10, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 13, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 12, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Jun 07, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jun 06, 2019

Correspondence

[Cover]Correspondence
Jun 04, 2019

Major Issues Report

Current report, item 5.07
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]